2. DRUG ROA USE SIDE EFFECTS
Acyclovir Oral
Topical
IV
Herpes Encephalitis
Genital Herpes
Orolabial Herpes
Varicella Zoster
Nephrotoxicity ,
Renal or CNS toxicity
NUCLEOSIDE INHIBITORS
CONTD
Famciclovir Oral Orolabial Herpes,
Zoster,Genital
Herpes,EBV,HBV
Headache,
nausea, or diarrhea
3. CONTD
DRUG ROA USE Side Effects
Ganciclovir IV
Oral
Intraocular implant
CMV retinitis treatment
CMV prophylaxis
CMV retinitis treatment
CMV retinitis treatment
Leukopenia &
thrombocytopenia as a
result of
Myelosuppression
Cidofovir Intravenous CMV retinitis treatment
Fanconi’s syndrome
4. DRUG ROA USE SIDE EFFECTS
Valacyclovir(no IV) Oral Herpes Encephalitis,Genital
Herpes
Gastrointestinal
intolerance
as well as thrombotic
thrombocytopenic purpura
and
hemolytic-uremic syndrome
Valganciclovir Oral
Oral
CMV retinitis
CMV prophylaxis
Leukopenia,
thrombocytopenia,
Myelosuppression
CONTD
5. DRUG ROA USE SIDE EFFECTS
Entecavir Oral Chronic hepatitis B Headache, fatigue,
dizziness, and nausea
Telbivudine Oral Chronic hepatitis B Nausea and vomiting
,myalgia myopathy
,neuropathy
Ribavirin Oral Influenza A and
B, parainfluenza,
paramyxoviruses,
HCV, and HIV-1
Anemia,
end-stage renal failure,
ischemic vascular disease,
8. AGENT ROA USE SIDE EFFECTS
Oseltamivir Oral influenza A and
influenza B
viruses
Nausea and abdominal pain
(gastric irritation)
Headache, weakness, sadness,
diarrhea, cough, and insomnia
Skin reactions
Zanamivir Intranasal influenza A and
influenza B
viruses
Bronchospasm in asthmatic
patients
NEURAMINIDASE INHIBITORS
9. AGENT ROA USE SIDE EFFECTS
AMANTADINE &
RIMANTADINE
Oral Influenza A Gastrointestinal (nausea,
anorexia) and central nervous system
(nervousness, difficulty in
concentrating, insomnia, light-headedness)
Other Anti-Influenza Agents
Acyclovir- no activity against CMV
* In first episodes of genital
herpes, oral acyclovir shortens the duration of symptoms by
approximately 2 days, the time to lesion healing by 4 days, and the
duration of viral shedding by 7 days.
*prophylaxis in AIDS
Ganciclovir-The risk of
Kaposi’s sarcoma is reduced in AIDS patients receiving long-term
ganciclovir
Cidofovir- also treatment of HPV infec and pox virus
Valacyclovir- It is
rapidly converted to acyclovir after oral administration via firstpass
enzymatic hydrolysis in the liver and intestine, resulting in
serum levels that are three to five times greater than those achieved
with oral acyclovir and approximate those achieved with intravenous
acyclovir.
Entecavir- it should be taken in an empty stomach to approach 100% bioavailability
Ribavarin-rb is effective orallly and should avoid antacids
*no benefit on RSV treatment
Foscarnet-The combination of ganciclovir and foscarnet is synergistic in
vitro against CMV
Oseltamivir is
approved by the Food and Drug Administration (FDA) for
patients 1 year and older, whereas zanamivir is approved in
patients 7 years or older.
zanamivir not given to patients underlying airway disease
rimantadine 4-10 times more active than amantadine
Zidovudine was the first antiretroviral agent to be approved
and has been well studied
*it is available in combination with lamivudine